Cargando…
Severe Infections in Patients Treated with Tocilizumab for Systemic Diseases Other Than Rheumatoid Arthritis: A Retrospective Multicenter Observational Study
OBJECTIVE: This study aimed to describe severe infections in patients treated with tocilizumab for systemic diseases other than rheumatoid arthritis. METHODS: Data from patients receiving at least 2 doses of tocilizumab for systemic diseases other than rheumatoid arthritis between January 1, 2012, a...
Autores principales: | Broca, Florent, Souchaud-Debouverie, Odile, Liuu, Evelyne, Roblot, Pascal, Martin, Mickaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mesut Onat
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152110/ https://www.ncbi.nlm.nih.gov/pubmed/36135932 http://dx.doi.org/10.5152/eurjrheum.2022.22028 |
Ejemplares similares
-
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016) -
Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008) -
Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014) -
Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017) -
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study
por: Pierini, Florencia S., et al.
Publicado: (2021)